The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Poor availability of essential medicines for women and children threatens progress towards Sustainable Development Goal 3 in Africa
Open accessAbstract
Background: Most maternal and child deaths are preventable or treatable with proven, cost-effective interventions for infectious diseases and maternal and neonatal complications. In 2015 sub-Saharan Africa accounted for up to 66% of global maternal deaths and half of the under-five deaths. Access to essential medicines and commodities and trained healthcare workers to provide life-saving maternal, newborn and post-natal care are central to further reductions in maternal and child mortality. Methods: Available data for 24 priority medicines for women and children were extracted from WHO service availability and readiness assessments conducted between 2012 and 2015 for eight countries in sub-Saharan Africa. The mean availability of medicines in facilities stating they provide services for women or children and differences by facility type, ownership and location are reported. Results: The mean availability of 12 priority essential medicines for women ranged from 22% to 40% (median 33%; IQR 12%) and 12 priority medicines for children ranged from 28% to 57% (median 50%; IQR 14%). Few facilities (<1%) had all nominated medicines available. There was higher availability of priority medicines for women in hospitals than in primary care facilities: range 32%–80% (median 61%) versus 20%–39% (median 23%) and for children’s medicines 31%–71% (median 58%) versus 27%–57% (median 48%). Availability was higher in public than private facilities: for women’s medicines, range 21%–41% (median 34%) versus 4%–36% (median 27%) and for children’s medicines 28%–58% (median 51%) versus 5%–58% (median 46%). Patterns were mixed for rural and urban location for the priority medicines for women, but similar for children’s medicines. Conclusions: The survey results show unacceptably low availability of priority medicines for women and children in the eight countries. Governments should ensure the availability of medicines for mothers and children if they are to achieve the health sustainable development goals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Low investment in essential medicines for health, a lack of comprehensive health financing policies and strategic plans, extensive out-of-pocket payments, a lack of social safety nets to protect the poor, poor financial management, inefficient resource allocation and use, and weak mechanisms for coordinating partner support constrain health financing in the African region.30,41”
From Challenges to the Availability and Affordability of Essential Medicines in African Countries: A Scoping Review (2023) · cites this paper as [30]
Experimental — accuracy not yet measuredIn the citing paper
“Low investment in essential medicines for health, a lack of comprehensive health financing policies and strategic plans, extensive out-of-pocket payments, a lack of social safety nets to protect the poor, poor financial management, inefficient resource allocation and use, and weak mechanisms for coordinating partner support constrain health financing in the African region.30,41”
From Challenges to the Availability and Affordability of Essential Medicines in African Countries: A Scoping Review (2023) · cites this paper as [30]
In the citing paper
“Low investment in essential medicines for health, a lack of comprehensive health financing policies and strategic plans, extensive out-of-pocket payments, a lack of social safety nets to protect the poor, poor financial management, inefficient resource allocation and use, and weak mechanisms for coordinating partner support constrain health financing in the African region.30,41”
From Challenges to the Availability and Affordability of Essential Medicines in African Countries: A Scoping Review (2023) · cites this paper as [30]
In the citing paper
“When, where, where from, which one, how much, and how many times; in short, the fundamental parameters required for a successful supply chain setup are highly uncertain.30,39”
From Challenges to the Availability and Affordability of Essential Medicines in African Countries: A Scoping Review (2023) · cites this paper as [30]
In the citing paper
“Low investment in essential medicines for health, a lack of comprehensive health financing policies and strategic plans, extensive out-of-pocket payments, a lack of social safety nets to protect the poor, poor financial management, inefficient resource allocation and use, and weak mechanisms for coordinating partner support constrain health financing in the African region.30,41”
From Challenges to the Availability and Affordability of Essential Medicines in African Countries: A Scoping Review (2023) · cites this paper as [30]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global causes of maternal death: a WHO systematic analysis
Say, L., Chou, D., Gemmill, A., Tunçalp, Ö., Moller, A.-B., Daniels, J., Gülmezoglu, A. M., Temmerman, M., & Alkema, L. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70227-x · Cited by 6,582 · cited 2×
“1 Postpartum haemorrhage was the leading cause of maternal death in low-income countries, with death rates around 150 per 100 000 deliveries in sub-Saharan Africa compared with 0.4 per 100 000 in the UK.”
InfluentialLevels and trends in child mortality, 1990–2009
You, D., Jones, G., Hill, K., Wardlaw, T., & Chopra, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61429-8 · Cited by 790
Suzuki, E., Mathers, C. D., Moller, A., Alkema, L., Say, L., Gemmill, A., Mills, S. L., Chou, D., & Hogan, D. R. (2014) · Cited by 680
Every Newborn: An Action plan to end preventable deaths
New, K. (2013) · Cited by 584
Torloni, M., Freitas, C. G., Kartoğlu, Ü., Gülmezoglu, A. M., & Widmer, M. (2016) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13998 · Cited by 140
Cleary, J. F., Radbruch, L., Torode, J., & Cherny, N. I. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt500 · Cited by 135
Bedford, K. J. A., & Sharkey, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100038 · Cited by 121
Cleary, J. F., Powell, R. A., Munene, G., Mwangi-Powell, F. N., Luyirika, E. B. K., Kiyange, F., Merriman, A., Scholten, W. K., Radbruch, L., Torode, J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt499 · Cited by 87
Anyakora, C., Oni, Y., Ezedinachi, U., Adekoya, A., Ali, I., Nwachukwu, C. U., Esimone, C. O., Abiola, V. O., & Nwokike, J. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1671-y · Cited by 75
Medicines availability for non-communicable diseases: the case for standardized monitoring
Robertson, J., Macé, C., Forte, G. B., de Joncheere, K., & Beran, D. (2015) · Globalization and Health · doi:10.1186/s12992-015-0105-0 · Cited by 60
Self-citation
Cited by
Sustainable Development Goals relevant to kidney health: an update on progress
Luyckx, V. A., Al-Aly, Z., Bello, A. K., Bellorin-Font, E., Carlini, R. G., Fabian, J., Garcia-Garcia, G., Iyengar, A., Sekkarie, M., van Biesen, W., et al. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00363-6 · Cited by 221
Yenet, A., Nibret, G., & Tegegne, B. A. (2023) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s413546 · Cited by 202
“30,39 A workshop by WHO (2006) outlines the difficulties of the medicine supply in African countries; the main barriers are poor information, communication, and consumption data, inadequate storage facilities and temperature control systems, and a lack of quality assurance procedures.”
InfluentialOoms, G. I., Kibira, D., Reed, T., van den Ham, H. A., Mantel-Teeuwisse, A. K., & Buckland‐Merrett, G. (2020) · BMC Public Health · doi:10.1186/s12889-020-09155-w · Cited by 56
Deressa, M. B., Beressa, T. B., & Jemal, A. (2022) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s354810 · Cited by 46
Piggott, T., Nowak, A. J., Brignardello‐Petersen, R., Cooke, G., Huttner, B. D., Schünemann, H. J., Persaud, N., Magrini, N., & Moja, L. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-053349 · Cited by 44
Metadata
- Authors
- Droti, B., O’Neill, K. P., Mathai, M., Yao Tsidi Dovlo, D., & Robertson, J.
- Affiliations
- World Health Organization (CH)
- World Health Organization - Denmark (DK)
- Health Systems and Services Cluster, World Health Organization, Regional Office for Africa, Brazzaville, Congo
- World Health Organization Regional Office for Europe (DK)
- Corresponding author
- Droti, Benson
- Venue
- BMJ Global Health
- Publisher
- BMJ
- Published
- 2019-10
- Volume
- 4
- Issue
- Suppl 9
- Pages
- e001306
- ISSN
- 2059-7908 (ISSN-L)
- PMC
- PMC6797404
- OpenAlex
- W2978939006
- Cited by
- 51
- References
- 21
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 8 · 2023: 15 · 2022: 8 · 2021: 5 · 2020: 6 · 2019: 1
- Type
- conference abstract
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Global Health (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- NOVA (University of Newcastle Australia) (submittedVersion)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
- Keywords
- essential medicines availability, maternal health, child health, maternal mortality, under-five mortality, Sustainable Development Goal 3, sub-Saharan Africa, healthcare facilities, primary care, hospitals, urban-rural differences
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Poor availability of essential medicines for women and children threatens progress towards Sustainable Development Goal 3 in Africa. https://app.cochat.ai/papers/10.1136/bmjgh-2018-001306
- The paper
- Droti, B., O’Neill, K. P., Mathai, M., Yao Tsidi Dovlo, D., & Robertson, J. (2019). Poor availability of essential medicines for women and children threatens progress towards Sustainable Development Goal 3 in Africa. BMJ Global Health. https://doi.org/10.1136/bmjgh-2018-001306
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.